asa glp-1 πΈ Should RAs be continued preprocedurally? πΈ Who should stop a GLP-1 RA preoperatively? πΈ Which patients should have their procedures postponed? Read: https://doi.org/10.1097/01.ASM.0001125664.22893.9f GLP-1RA Essentials in Gastroenterology: Side
Description
approved Wegovy (semaglutide) by Novo Nordisk A/S, making it available to thousands of people with obesity in England

Our research is strong proof that these medicines are not just continuing to gain usage, but also that those that cover them see them as beneficial to have in a plan for at least some portion of the population
Each dose increase happens at four-week intervals, so reaching the full dose takes about 16 to 20 weeks
Launched in July after fallout with Eli Lilly, Nooms microdose platform combines compounded low-dose GLP-1s with 1:1 coaching and personalized support

Retatrutide is administered as a once-weekly subcutaneous injection
